Andersen-Tawil syndrome – Diagnostics

Go back

Andersen-Tawil syndrome is a rare genetic disorder that affects the heart, muscles, and physical development, requiring careful diagnostic evaluation to identify its distinctive pattern of symptoms and guide appropriate medical care.

Introduction: Who Should Undergo Diagnostics

Diagnostic testing for Andersen-Tawil syndrome should be considered when someone experiences episodes of sudden muscle weakness that come and go, especially if these episodes began during childhood or the teenage years. These periods of weakness can last anywhere from a few hours to several days, and they may happen after physical activity, following rest, or sometimes without any obvious reason at all.[1]

Anyone experiencing irregular heartbeats or a sensation that their heart is skipping beats, known as palpitations, should seek medical evaluation. This is particularly important when these heart symptoms occur alongside episodes of muscle weakness. In some cases, the irregular heartbeat may cause fainting spells, which doctors call syncope. Although rare, these heart rhythm problems can potentially lead to serious complications if left undiagnosed and untreated.[2]

Physical features can also prompt diagnostic investigation. If a child or adult has certain distinctive facial or body characteristics, such as a very small lower jaw, low-set ears, eyes that are spaced farther apart than usual, or unusual curving of the fingers or toes, these signs may suggest the need for testing. These physical features, combined with either muscle weakness or heart rhythm problems, create a pattern that doctors recognize as potentially indicating Andersen-Tawil syndrome.[3]

Family history plays an important role in deciding who should be tested. If someone has a close relative diagnosed with Andersen-Tawil syndrome or a family member who experienced similar symptoms or sudden cardiac death at a young age, medical evaluation is strongly recommended. The condition can run in families, and early diagnosis can help prevent serious complications.[1]

⚠️ Important
If you experience fainting spells alongside muscle weakness or have a family history of sudden cardiac death, seek medical attention promptly. While Andersen-Tawil syndrome carries a lower risk of sudden death compared to other heart rhythm disorders, the heart complications still require careful monitoring and appropriate medical management.

Classic Diagnostic Methods

Diagnosing Andersen-Tawil syndrome involves multiple approaches because the condition affects different parts of the body. Doctors typically begin with a thorough medical history and physical examination, looking for the characteristic combination of symptoms: periodic muscle weakness, heart rhythm abnormalities, and distinctive physical features. The presence of all three features supports the diagnosis, although some people may only show one or two of these aspects.[2]

One of the most important diagnostic steps is checking blood potassium levels during an episode of muscle weakness. Potassium is a mineral that helps muscles work properly, and abnormal levels can indicate which type of periodic paralysis someone has. In many cases of Andersen-Tawil syndrome, potassium levels may be low during an attack, though sometimes they remain within the normal range. Obtaining a blood sample during an actual episode of weakness is crucial because potassium levels often return to normal once the episode passes.[2]

An electrocardiogram, or EKG, is a simple test that records the electrical activity of the heart. This test is essential for diagnosing Andersen-Tawil syndrome because it can reveal a prolonged QT interval, which means the heart takes longer than normal to recharge between beats. The EKG may also show abnormal heart rhythms, including a specific pattern called bidirectional ventricular tachycardia, where the heart’s lower chambers beat too quickly in an unusual alternating pattern. This particular type of irregular heartbeat is quite characteristic of Andersen-Tawil syndrome.[3]

A 24-hour Holter monitor provides continuous heart rhythm recording while a person goes about their normal daily activities. This extended monitoring can detect irregular heartbeats that might not appear during a brief EKG test in the doctor’s office. The Holter monitor can capture episodes of ventricular ectopy, which are extra heartbeats originating from the heart’s lower chambers, as well as periods of sustained abnormal rhythm.[2]

Genetic testing has become an important diagnostic tool for Andersen-Tawil syndrome. About 60 percent of people with this condition have mutations in a gene called KCNJ2. This gene provides instructions for making channels that move potassium in and out of muscle cells. When there is a mutation in this gene, the condition is classified as type 1, or ATS1. In the remaining 40 percent of cases, genetic testing may not identify a specific mutation, and these cases are called type 2, or ATS2. Even when genetic testing does not find a mutation, a person can still have Andersen-Tawil syndrome based on their symptoms and other test results.[1]

An echocardiogram uses sound waves to create moving pictures of the heart. This test helps doctors examine the heart’s structure and function, checking for any abnormalities in how the heart pumps blood. While people with Andersen-Tawil syndrome typically have hearts that appear structurally normal, this test helps rule out other heart conditions that might cause similar symptoms.[14]

Specialized muscle testing called electromyography, or EMG, may be performed using a modified protocol called the McManis exercise test. During this test, muscles are stimulated after exercise to see how they respond. In people with Andersen-Tawil syndrome, the test may show characteristic changes in muscle electrical activity that support the diagnosis. This test can be particularly helpful when genetic testing is negative but symptoms strongly suggest periodic paralysis.[2]

Doctors must distinguish Andersen-Tawil syndrome from other conditions that cause similar symptoms. Other forms of long QT syndrome can cause heart rhythm problems but do not typically involve muscle weakness or distinctive physical features. Some forms, such as Jervell and Lange-Nielsen syndrome, are associated with hearing loss, which helps doctors tell them apart from Andersen-Tawil syndrome. Timothy syndrome, another long QT condition, involves structural heart abnormalities that are not seen in Andersen-Tawil syndrome.[3]

Testing thyroid function is also important because an overactive thyroid gland can cause a type of periodic paralysis that looks similar to Andersen-Tawil syndrome. Blood tests measuring thyroid hormone levels help doctors rule out thyroid-related causes of muscle weakness. This is especially important in people of Asian descent, as thyrotoxic periodic paralysis is more common in this population.[13]

Diagnostics for Clinical Trial Qualification

When someone is being considered for enrollment in a clinical trial studying Andersen-Tawil syndrome, additional diagnostic testing and documentation may be required beyond standard clinical diagnosis. Clinical trials typically have specific criteria that participants must meet, and these criteria help researchers ensure they are studying a uniform group of patients to obtain meaningful results.[2]

Genetic confirmation is often a key requirement for clinical trial participation. Trials may specifically enroll only patients with confirmed KCNJ2 gene mutations, which would be those with type 1 Andersen-Tawil syndrome. This is because researchers want to study people with the same genetic cause of the condition to better understand how the disease works and how treatments might help. Genetic testing must be performed at a qualified laboratory, and the specific mutation must be documented in the person’s medical records.[1]

Detailed cardiac evaluation is typically required before someone can join a clinical trial. This usually includes a standard 12-lead EKG to document the QT interval and identify any abnormal heart rhythms. The EKG results must clearly show the characteristic features of Andersen-Tawil syndrome. Many trials also require a 24-hour Holter monitor recording to document the frequency and type of irregular heartbeats over an extended period. This baseline information helps researchers track whether a treatment affects heart rhythm during the trial.[2]

Documentation of periodic paralysis episodes is another standard requirement. Clinical trials may ask participants to keep detailed records of muscle weakness episodes, including how often they occur, how long they last, what triggers them, and how severe they are. Some trials require that participants have experienced a minimum number of episodes within a specific time period before enrollment. Blood potassium levels measured during at least one attack may also need to be documented.[7]

Physical examination findings must be carefully documented for clinical trial screening. Researchers may take measurements and photographs of physical features such as jaw size, ear position, eye spacing, and finger or toe abnormalities. This documentation helps confirm the diagnosis and provides baseline information about physical characteristics that might be affected by the condition or its treatment.[2]

Assessment of muscle strength and function using standardized testing methods is often required. These tests measure how strong different muscle groups are and may include specific strength measurements using specialized equipment. Participants may also undergo muscle function tests that evaluate how well muscles work during activities. These baseline measurements help researchers determine whether a treatment improves muscle function during the trial.[2]

Some clinical trials may require screening for learning difficulties or cognitive function, as mild learning challenges and specific patterns of thinking difficulties have been described in people with Andersen-Tawil syndrome. These tests help researchers understand the full range of effects the condition has and whether treatments might help with these aspects of the syndrome. The tests typically assess areas like executive function, which involves planning and organizing, and abstract reasoning, which involves understanding complex ideas.[2]

Family history documentation is often collected during clinical trial screening. Researchers may ask for detailed information about relatives who have the condition or similar symptoms, as well as any family history of sudden cardiac death. This information helps researchers understand the inheritance pattern of the condition and may provide insights into how the disease affects different family members.[1]

Annual screening recommendations for people with confirmed Andersen-Tawil syndrome include yearly EKG and 24-hour Holter monitoring, even if symptoms are not present. These regular tests help doctors monitor the condition over time and detect any changes in heart rhythm that might require treatment. This ongoing monitoring is particularly important for family members who have the genetic mutation but have not yet developed symptoms.[2]

Ongoing Clinical Trials on Andersen-Tawil syndrome

  • Study of flecainide alone or with beta-blockers or calcium channel blockers and quinidine for treating ventricular arrhythmias in patients with Andersen-Tawil syndrome and MEPPC

    Recruiting

    3 1 1 1
    Investigated diseases:
    The Netherlands

References

https://medlineplus.gov/genetics/condition/andersen-tawil-syndrome/

https://www.ncbi.nlm.nih.gov/books/NBK1264/

https://en.wikipedia.org/wiki/Andersen%E2%80%93Tawil_syndrome

https://www.innovationsincrm.com/cardiac-rhythm-management/articles-2015/november/783-andersentawil-syndrome

https://www.youtube.com/watch?v=R_gH6hGRvJs

https://pubmed.ncbi.nlm.nih.gov/17395133/

https://www.ncbi.nlm.nih.gov/books/NBK1264/

https://medlineplus.gov/genetics/condition/andersen-tawil-syndrome/

https://www.ncbi.nlm.nih.gov/books/NBK1264/

https://thinkgenetic.org/diseases/andersen-tawil-syndrome/

https://www.youtube.com/watch?v=R_gH6hGRvJs

https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=134&contentid=594

https://www.neurologylive.com/view/insider-tips-periodic-paralysis-issues-developing-comprehensive-treatment-plan

https://www.jmedicalcasereports.org/article_html.php?did=14551&issueno=0

https://medlineplus.gov/diagnostictests.html

https://www.questdiagnostics.com/

https://www.healthdirect.gov.au/diagnostic-tests

https://www.who.int/health-topics/diagnostics

https://www.nibib.nih.gov/science-education/science-topics/rapid-diagnostics

https://www.yalemedicine.org/clinical-keywords/diagnostic-testsprocedures

https://www.health.harvard.edu/diagnostic-tests-and-medical-procedures

FAQ

Can Andersen-Tawil syndrome be diagnosed without genetic testing?

Yes, Andersen-Tawil syndrome can be diagnosed based on characteristic clinical features and EKG findings even without finding a genetic mutation. About 40 percent of people with the condition do not have an identifiable KCNJ2 gene mutation, but they still have the syndrome based on their symptoms including periodic paralysis, heart rhythm abnormalities, and distinctive physical features.

Why is it important to check potassium levels during a muscle weakness episode?

Checking potassium levels during an actual episode of weakness is crucial because potassium levels often return to normal between episodes. Low potassium during an attack suggests hypokalemic periodic paralysis, while normal levels don’t rule out the diagnosis. This information helps doctors distinguish Andersen-Tawil syndrome from other conditions that cause similar muscle weakness.

What is the difference between a regular EKG and a Holter monitor?

A regular EKG provides a snapshot of your heart’s electrical activity during a brief period in the doctor’s office, usually lasting just a few seconds. A Holter monitor records your heart rhythm continuously for 24 hours while you go about your normal activities, making it more likely to catch irregular heartbeats that come and go throughout the day.

Should my family members be tested if I have Andersen-Tawil syndrome?

Yes, parents and siblings should be evaluated by a cardiologist or neurologist and consider genetic testing. The condition is inherited in an autosomal dominant pattern, meaning children of someone with Andersen-Tawil syndrome have a 50 percent chance of inheriting the genetic mutation. Annual EKG and Holter monitoring is recommended for family members who carry the mutation, even if they don’t have symptoms yet.

What other conditions might be confused with Andersen-Tawil syndrome?

Several conditions can be confused with Andersen-Tawil syndrome, including other forms of long QT syndrome like Romano-Ward syndrome and Jervell and Lange-Nielsen syndrome, which includes hearing loss. Timothy syndrome involves structural heart abnormalities. Thyrotoxic periodic paralysis, caused by an overactive thyroid, can also mimic the muscle weakness seen in Andersen-Tawil syndrome, which is why thyroid testing is important.

🎯 Key takeaways

  • Diagnostic testing should be considered when someone experiences episodes of muscle weakness combined with heart palpitations or distinctive physical features like a small jaw, low-set ears, or widely spaced eyes.
  • Checking blood potassium levels specifically during a muscle weakness episode is crucial, as levels often normalize between attacks and provide important clues about which type of periodic paralysis is present.
  • A 24-hour Holter monitor is more effective than a brief EKG at catching irregular heartbeats that come and go throughout the day, making it an essential diagnostic tool for Andersen-Tawil syndrome.
  • Only about 60 percent of people with Andersen-Tawil syndrome test positive for the known KCNJ2 gene mutation, meaning a negative genetic test doesn’t rule out the condition if symptoms are present.
  • Family members of someone diagnosed with Andersen-Tawil syndrome should undergo cardiac and neurological evaluation, as the condition can be inherited and early detection helps prevent serious complications.
  • Distinguishing Andersen-Tawil syndrome from other forms of long QT syndrome and thyroid-related periodic paralysis requires multiple tests including thyroid function studies and comprehensive cardiac evaluation.
  • Clinical trial participation typically requires genetic confirmation, detailed documentation of paralysis episodes, comprehensive cardiac testing, and standardized muscle strength measurements to meet specific enrollment criteria.
  • Annual EKG and 24-hour Holter monitoring is recommended even for people who carry the genetic mutation but haven’t developed symptoms yet, helping doctors monitor for changes that might require treatment.